Contradictory findings from a meta-analysis and the EPISODE trial highlight both the promise of psychedelics and ongoing issues with blinding in psychedelic trials.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/mixed-results-psilocybin-blinding-concerns-remain-2026a10008id?src=rss
Author :
Publish date : 2026-03-20 08:37:00
Copyright for syndicated content belongs to the linked Source.